Faculty Profile

Dr. Tiffany Lu, M.D.

Tiffany Lu, M.D.

Assistant Professor, Department of Medicine (General Internal Medicine)

Professional Interests

Tiffany Lu, MD, MS is an Assistant Professor of Medicine in the Division of General Internal Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. Her clinical and educational work centers around opioid use disorder treatment, overdose prevention, and HIV prevention and care. Dr. Lu is the medical director of the Montefiore Buprenorphine Treatment Network, where she leads federal, state, and city funded grants implement opioid use disorder treatment and overdose prevention education in general medical care. Dr. Lu also directs Montefiore’s Project ECHO for Opioid Use Disorder Treatment, a tele-mentoring program to support New York State clinical practitioners in providing opioid use disorder treatment. Dr. Lu’s research is focused on outcomes of buprenorphine treatment and naloxone distribution in urban medical settings with high prevalence of opioid use disorder and overdose. 

Prior to joining Montefiore-Einstein, Dr. Lu graduated from University of California in San Francisco (UCSF) School of Medicine and completed her residency training in the Primary Care Internal Medicine Residency Program at Massachusetts General Hospital. She is board certified with the American Board of Internal Medicine and credentialed as HIV specialist with the American Academy of HIV Medicine. She also received her Masters of Science in Clinical Research from Albert Einstein College of Medicine.

Selected Awards & Honors

National Institute of Drug Abuse & Society of General Internal Medicine Mentored Training Award in Substance Use Disorder Treatment and Science Dissemination (2017)

New York State Empire Clinical Research Investigator Program Fellowship (2017)

Montefiore-Einstein Young Research Investigators Symposium Prize (2018)

Selected Publications

Slawek D, Lu T, Hayes B, and Fox AD. Caring for patients with opioid use disorder – what clinicians should know about comorbid medical conditions. Psych Res Clin Pract 2019; 1:16-26. doi: 10.1176/appi.prcp.20180005

Lu T“Buprenorphine Treatment at 10 Years: Trends in an Urban Community Health Center.” Association for Medical Education and Research in Substance Abuse (AMERSA) 2017 Annual Conference, Washington DC, 2017 Nov 4.

Lu T“Buprenorphine Treatment Outcomes among Opioid-Dependent Marijuana Users and Non-Users.” AMERSA 2017 Annual Conference, Washington DC, 2017 Nov 2.

Lu T. Why Abuse-Deterrent Opioids Are Not the Solution to the Opioid Epidemic. Albert Einstein College of Medicine – The Doctor’s Tablet. 2018 Jul 6.

Lu T, Zwicker L, Kwena Z, et al. Assessing barriers and facilitators of implementing an integrated HIV prevention and property rights program in Western Kenya. AIDS Educ Prev 2013;25(2):151-63.

Dworkin SL, Grabe S, Lu T, et al. Property Rights Violations as a Structural Driver of Women’s HIV Risks: A Qualitative Study in Nyanza & Western Provinces, Kenya. Arch Sex Behav 2013;42(5):703-13.

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Montefiore Medical Group
1621 Eastchester Road
Bronx, NY 10461

Tel: 718.405.8040
Fax: 718.405.8050

Research Information